Clinical Trial Update: Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating albumin-bound paclitaxel plus S-1 as first-line chemotherapy for advanced or recurrent gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED